Keystone Symposia

Filters

Show only products with CE credit

Product Type

Session
27

General

HIV

HIV (27)

Specialties

Speakers

Sort Order

Showing results 1 - 20 of 27

HIV/AIDS: Strategies for an Endgame
Date
April 1, 2020
HIV/AIDS: STRATEGIES FOR AN ENDGAME
Moderator
Bruce D. Walker, MD
Ragon Institute of MGH, MIT and Harvard
Panelists
Myron S. Cohen, MD
University of North Carolina at Chapel Hill
Betsy Herold, MD
Albert Einstein College of Medicine
Julie McElrath, MD, PhD
Fred Hutchinson Cancer Research Center (FHCRC)
Gary Nabel, MD, PhD
Sanofi
Free
Standard Price
Ending the HIV/AIDS Pandemic: Follow the Science
Date
September 6, 2019
ENDING THE HIV/AIDS PANDEMIC: FOLLOW THE SCIENCE - ANTHONY S…
Speaker
Anthony S. Fauci, MD
NIAID, National Institutes of Health
Free
Standard Price
Towards an HIV Vaccine: A Scientific Journey
Date
September 6, 2019
TOWARDS AN HIV VACCINE: A SCIENTIFIC JOURNEY
Speaker
Anthony S. Fauci, MD
NIAID, National Institutes of Health
Free
Standard Price
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Date
September 6, 2019
Recorded during the Keystone Symposia meeting:
Speaker
Till Schoofs, MD
The Rockefeller University
Free
Standard Price
Deciphering the molecular basis of unusually high neutralization resistance in a tier 3 HIV-1 strain
Date
September 6, 2019
DECIPHERING THE MOLECULAR BASIS OF UNUSUALLY HIGH NEUTRALIZATION RESISTANCE IN A TIER 3 HIV-1 STRAIN
Speaker
Thandeka Moyo, PhD
University of Cape Town
Free
Standard Price
Individualized Profiling of Germline Antibody V Genes
Date
September 6, 2019
Recorded during the Keystone Symposia meeting:
Speaker
Gunilla K. Hedestam
Karolinska Institutet
Free
Standard Price
B Cell Clonal Dynamics During Sequential Immunizations
Date
September 6, 2019
Recorded during the Keystone Symposia meeting:
Speaker
Thomas B. Kepler, PhD
Boston University
Free
Standard Price
F9, a new class of antibodies that neutralizes autologous tier 2 viruses in NHP immunized with liposome conjugated well-ordered trimers
Date
September 6, 2019
Recorded during the Keystone Symposia meeting:
Speaker
Paola Murillo
Karolinska Institutet
Free
Standard Price
Antiretroviral treatment of acute HIV infection and the prospect for a functional cure
Date
September 6, 2019
Recorded during the Keystone Symposia meeting:
Speaker
Thumbi Ndung’u, BVM, PhD
University of KwaZulu-Natal
Free
Standard Price
Broadly neutralizing antibodies development: Lessons from the Protocol C cohort
Date
September 6, 2019
Recorded during the Keystone Symposia meeting:
Speaker
Elise Landais, PhD
IAVI Neutralizing Antibody Center
Free
Standard Price
HIV Vaccine Humoral Immunity, Immune Correlates and Mechanistic Insights.
Date
September 6, 2019
VACCINE HUMORAL IMMUNITY, IMMUNE CORRELATES AND MECHANISTIC INSIGHTS
Speaker
Georgia Tomaras, PhD
Duke Human Vaccine Institute,
Free
Standard Price
Profiling protective antibody responses
Date
September 6, 2019
PROFILING PROTECTIVE ANTIBODY RESPONSES
Speaker
Margaret E. Ackerman, PhD
Principal Investigator , Thayer School of Engineering at Dartmouth College
Free
Standard Price
A Broadly Neutralizing Antibody from an Elite Neutralizer Target a Novel Site at the gp120-gp41 Interface
Date
September 6, 2019
A BROADLY NEUTRALIZING ANTIBODY FROM AN ELITE NEUTRALIZER TARGET A NOVEL SITE AT THE GP120-GP41 INTERFACE
Speaker
Marit J. van Gils, PhD
Academic Medical Center, University of Amsterdam, the Netherlands
Free
Standard Price
Novel Therapeutic Interventions in the Targeting of the HIV Cell Reservoir
Date
September 6, 2019
NOVEL THERAPEUTIC INTERVENTIONS IN THE TARGETING OF THE HIV CELL RESERVOIR
Speaker
Giuseppe Pantaleo, MD
Lausanne University Hospital
Free
Standard Price
AAV-expressed eCD4-lg as an HIV-1 vaccine alternative
Date
September 6, 2019
AAV-EXPRESSED ECD4-LG AS AN HIV-1 VACCINE ALTERNATIVE
Speaker
Michael Farzan, PhD
The Scripps Research Institute
Free
Standard Price
Importance of CD8 T Cell Responses Targeting Variable Epitopes in SIV
Date
September 6, 2019
IMPORTANCE OF CD8 T CELL RESPONSES TARGETING VARIABLE EPITOPES IN SIV
Speaker
Matthew Sutton
University of Wisconsin-Madison
Free
Standard Price
Structural Studies of HIV-1 Infection
Date
September 6, 2019
STRUCTURAL STUDIES OF HIV-1 INFECTION
Speaker
Pamela J. Bjorkman, PhD
California Institute of Technology
Free
Standard Price
HIV Vaccines: Path to Efficacy
Date
September 6, 2019
HIV VACCINES: PATH TO EFFICACY
Moderator
Gabriella Scarlatti, MD, PhD
Global HIV Vaccine Enterprise
Panelists
Barton F. Haynes, MD
Professor of Medicine
Penny Moore, PhD
Nicole Frahm, PhD
Free
Standard Price
Sequential Immunizations with an Integrase Defective Lentiviral Vector Induce Higher Magnitude and More Durable Antibody Responses than DNA and Protein Based Vaccine Regimens
Date
September 6, 2019
Recorded during the Keystone Symposia meeting:
Speaker
Maria Blasi, PhD
Duke University Medical Center
Free
Standard Price
Exploring the effects of Schistosoma mansoni infection treatment on female HIV susceptibility
Date
June 12, 2019
BACKGROUND: The prevalence of infection with the trematode Schistosoma mansoni (Sm) exceeds 50% in many regions of sub-Saharan Africa, and there are ecologic and epidemiologic links with HIV acquisition…
Speaker
Sergey Yegorov, PhD
University of Toronto
Free
Standard Price

Moderator

Panelists

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Speaker

Moderator

Panelists

Speaker

Speaker